If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Rosalba Miceli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Survival Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Nomograms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 8680 Citations
  • 48 h-Index
  • 195 Article
  • 2 Comment/debate
  • 2 Review article
  • 1 Letter

Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors

Callegaro, D., Miceli, R., Bonvalot, S., Ferguson, P. C., Strauss, D. C., van Praag, V. V. M., Levy, A., Griffin, A. M., Hayes, A. J., Stacchiotti, S., Pèchoux, C. L., Smith, M. J., Fiore, M., Tos, A. P. D., Smith, H. G., Catton, C., Szkandera, J., Leithner, A., van de Sande, M. A. J., Casali, P. G. & 2 others, Wunder, J. S. & Gronchi, A., Dec 2019, In : EClinicalMedicine. 17, 100215.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

Dodero, A., Guidetti, A., Tucci, A., Barretta, F., Novo, M., Devizzi, L., Re, A., Passi, A., Pellegrinelli, A., Pruneri, G., Miceli, R., Testi, A., Pennisi, M., Di Chio, M. C., Matteucci, P., Carniti, C., Facchetti, F., Rossi, G. & Corradini, P., Apr 1 2019, In : Leukemia. 33, 4, p. 1047-1051 5 p.

Research output: Contribution to journalLetter

Open Access
2 Citations (Scopus)

Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer

Pietrantonio, F., Miceli, R., Raimondi, A., Kim, Y. W., Kang, W. K., Langley, R. E., Choi, Y. Y., Kim, K. M., Nankivell, M. G., Morano, F., Wotherspoon, A., Valeri, N., Kook, M. C., An, J. Y., Grabsch, H. I., Fucà, G., Noh, S. H., Sohn, T. S., Kim, S., Di Bartolomeo, M. & 4 others, Cunningham, D., Lee, J., Cheong, J. H. & Smyth, E. C., Dec 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 35, p. 3392-3400 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
Sarcoma
Recurrence
Survival
Neoplasms
Incidence

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Nichetti, F., Falvella, F. S., Miceli, R., Cheli, S., Gaetano, R., Fucà, G., Infante, G., Martinetti, A., Antoniotti, C., Falcone, A., Di Bartolomeo, M., Cremolini, C., de Braud, F. & Pietrantonio, F., Oct 1 2019, In : Pharmacogenomics Journal. 19, 5, p. 465-472 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Pharmacogenetics
Colorectal Neoplasms
Single Nucleotide Polymorphism